Sr.Rayala.Hypo

Why is Sree Rayalaseema Hi-Strength Hypo Ltd falling/rising?

As of 03-Aug, the stock price of Sree Rayalaseema Hi-Strength Hypo Ltd is currently at Rs 493.10, reflecting a short-term rise despite mixed performance over longer periods, including declines of 0.38% and 0.26% over the past week and month, respectively. The stock shows volatility, with significant drops in investor participation and a current price above some moving averages but below others.

As of 03-Aug, the stock price of Sree Rayalaseema Hi-Strength Hypo Ltd is rising, currently at Rs 493.10, reflecting an increase of Rs 10.25 or 2.12%. This rise can be attributed to its performance today, where it outperformed its sector by 1.1% and reached an intraday high of Rs 504.75, which is a 4.54% increase. <BR><BR>Despite this positive movement, the stock has shown a mixed performance over various periods. Over the past week and month, it has declined by 0.38% and 0.26%, respectively, while year-to-date, it is down 4.01%. Additionally, the stock has experienced a significant drop in investor participation, with delivery volume on July 31 falling by 79% compared to the 5-day average. <BR><BR>The stock's moving averages indicate that while it is currently higher than the 5-day, 20-day, and 100-day moving averages, it remains lower than the 50-day and 200-day moving averages, suggesting some volatility in its price trend. Overall, the current rise in the stock price appears to be a short-term reaction amidst a backdrop of declining performance in the longer term.

Which are the latest news on Sr.Rayala.Hypo?

Should I buy, sell or hold Sree Rayalaseema Hi-Strength Hypo Ltd?

How big is Sr.Rayala.Hypo?

As of 10th June, Sree Rayalaseema Hi-Strength Hypo Ltd has a market capitalization of 865.00 Cr, with net sales of 666.96 Cr and a net profit of 89.51 Cr reported in the latest four quarters.

As of 10th June, Sree Rayalaseema Hi-Strength Hypo Ltd has a market capitalization of 865.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, the company reported net sales of 666.96 Cr and a net profit of 89.51 Cr.<BR><BR>The latest annual period for the balance sheet is March 2025, showing shareholder's funds of 918.28 Cr and total assets of 1,069.60 Cr.

Who are in the management team of Sr.Rayala.Hypo?

The management team of Sr. Rayala. Hypo includes Tumbalam Gooty Bharath (Chairman & Managing Director), V Surekha (Company Secretary & Compliance Officer), and several directors, including Krishna Moorthy Chandraiah Naik, P. Ramachandra Gowd, A. Kailashnath, H Gurunath Reddy, and R Triveni (Independent Directors).

The management team of Sr. Rayala. Hypo includes the following individuals:<BR><BR>1. **Tumbalam Gooty Bharath** - Chairman & Managing Director<BR>2. **V Surekha** - Company Secretary & Compliance Officer<BR>3. **Krishna Moorthy Chandraiah Naik** - Director<BR>4. **P. Ramachandra Gowd** - Independent Director<BR>5. **A. Kailashnath** - Independent Director<BR>6. **H Gurunath Reddy** - Director<BR>7. **R Triveni** - Independent Director<BR><BR>If you need more information about any specific member or their roles, feel free to ask!

Who are the peers of the Sr.Rayala.Hypo?

Peers of Sr.Rayala.Hypo include I G Petrochems, Indo Borax & Ch., TGV Sraac, Andhra Sugars, Amines & Plast., Blue Pearl Agri, Sadhana Nitro, Tuticorin Alkali, and OCCL. Sr.Rayala.Hypo has below average management risk and growth ratings, with a 1-year return of -22.27%, better than Sadhana Nitro but worse than Indo Borax & Ch. at 77.84%.

Peers: The peers of Sr.Rayala.Hypo are I G Petrochems, Indo Borax & Ch., TGV Sraac, Andhra Sugars, Amines & Plast., Blue Pearl Agri, Sadhana Nitro, Tuticorin Alkali, OCCL.<BR><BR>Quality Snapshot: Excellent management risk is observed at I G Petrochems, Indo Borax & Ch., Andhra Sugars, Tuticorin Alkali, and OCCL, while Average management risk is found at TGV Sraac, Amines & Plast., Blue Pearl Agri, and Sadhana Nitro, and the rest. Below Average management risk is noted for Sr.Rayala.Hypo. Growth ratings show that Excellent growth is seen at Tuticorin Alkali and OCCL, while Average growth is found at Blue Pearl Agri, and the rest. Below Average growth is noted for I G Petrochems, Indo Borax & Ch., TGV Sraac, Andhra Sugars, Amines & Plast., Sr.Rayala.Hypo, and Sadhana Nitro. Capital Structure ratings indicate Excellent capital structure at I G Petrochems, Indo Borax & Ch., Andhra Sugars, Tuticorin Alkali, and OCCL, Good capital structure at TGV Sraac and Amines & Plast., and Below Average capital structure at Sadhana Nitro.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Indo Borax & Ch. at 77.84%, while the peer with the lowest is Sadhana Nitro at -86.72%. Sr.Rayala.Hypo's own 1-year return is -22.27%, which is significantly lower than Indo Borax & Ch. and higher than Sadhana Nitro. Additionally, the six-month return is negative for Blue Pearl Agri, Sadhana Nitro, and Chemfab Alka.

What does Sr.Rayala.Hypo do?

Sree Rayalaseema Hi-Strength Hypo Ltd is a micro-cap company specializing in the production of Calcium Hypochlorite, Stable Bleaching Powder, and Sulphuric Acid, with a market cap of INR 865 Cr and a net profit of 20 Cr as of March 2026. Key financial metrics include a P/E ratio of 9.00 and a dividend yield of 0.56%.

Overview: <BR>Sree Rayalaseema Hi-Strength Hypo Ltd is a leading producer of Calcium Hypochlorite, Stable Bleaching Powder, Sulphuric Acid, and other chemicals in the commodity chemicals industry, classified as a micro-cap company.<BR><BR>History: <BR>The company was incorporated in March 2005. The latest quarterly results reported are for March 2026, showing net sales and profit figures.<BR><BR>Financial Snapshot: <BR>- Net Sales: 163 Cr (Quarterly Results - Mar 2026) <BR>- Net Profit: 20 Cr (Quarterly Results - Mar 2026) <BR>- Market Cap: INR 865 Cr (Micro Cap) <BR><BR>Key Metrics: <BR>- P/E: 9.00 <BR>- Industry P/E: 42 <BR>- Dividend Yield: 0.56% <BR>- Debt Equity: -0.44 <BR>- Return on Equity: 10.06% <BR>- Price to Book: 0.89 <BR><BR>Contact Details: <BR>Address: Gondiparla, Kurnool Andhra Pradesh: 518004 <BR>Tel: 91-40-23313842 <BR>Fax: 91-40-23313875 <BR>Website: http://www.srhhl.com

Are Sree Rayalaseema Hi-Strength Hypo Ltd latest results good or bad?

Sree Rayalaseema Hi-Strength Hypo Ltd's latest results show a revenue increase of 15.56% to ₹163.14 crores, but a concerning 15.54% decline in net profit to ₹20.06 crores and a significant drop in operating margins to 8.15%. Overall, the financial health appears negative due to operational challenges and heavy reliance on non-operating income.

The latest results for Sree Rayalaseema Hi-Strength Hypo Ltd indicate a challenging performance. While the company reported a sequential revenue increase of 15.56% to ₹163.14 crores, its net profit fell by 15.54% to ₹20.06 crores, marking a decline both quarter-on-quarter and year-on-year. This drop in profit is concerning, especially as it reflects deteriorating operational efficiency.<BR><BR>The operating margin, excluding other income, decreased significantly to 8.15%, the lowest in eight quarters, down from 12.09% in the previous quarter. This margin compression suggests that the company is facing substantial operational challenges. Moreover, a high reliance on other income, which constituted 61.79% of profit before tax, raises questions about the sustainability of its earnings.<BR><BR>Overall, while revenue growth is a positive sign, the decline in profit and operating margins, coupled with heavy dependence on non-operating income, paints a negative picture of the company's current financial health. Investors should approach this situation with caution, as the underlying operational issues could signal deeper problems within the business.

When is the next results date for Sree Rayalaseema Hi-Strength Hypo Ltd?

The next results date for Sree Rayalaseema Hi-Strength Hypo Ltd is 30 May 2026.

The next results date for Sree Rayalaseema Hi-Strength Hypo Ltd is scheduled for 30 May 2026.

How has been the historical performance of Sr.Rayala.Hypo?

Sr.Rayala.Hypo has experienced declining net sales and profits from Mar'23 to Mar'25, with net sales dropping from 1,650.12 Cr to 637.82 Cr and profit after tax decreasing from 154.25 Cr to 87.47 Cr, despite some stabilization in cash flow and asset growth. Total liabilities and assets both increased during this period, indicating a challenging financial environment.

Answer:<BR>The historical performance of Sr.Rayala.Hypo shows significant fluctuations in key financial metrics over the years.<BR><BR>Breakdown:<BR>Sr.Rayala.Hypo's net sales have seen a decline from 1,650.12 Cr in Mar'23 to 637.82 Cr in Mar'25, indicating a downward trend in revenue. The total operating income followed a similar pattern, decreasing from 1,650.12 Cr in Mar'23 to 637.82 Cr in Mar'25. The company's total expenditure also decreased from 1,472.43 Cr in Mar'23 to 545.78 Cr in Mar'25, reflecting a reduction in operational costs. Operating profit (PBDIT) has shown a decline from 211.80 Cr in Mar'23 to 131.51 Cr in Mar'25, while profit before tax increased from 190.42 Cr in Mar'23 to 119.15 Cr in Mar'25. The profit after tax also decreased from 154.25 Cr in Mar'23 to 87.47 Cr in Mar'25. On the balance sheet, total liabilities rose from 945.02 Cr in Mar'23 to 1,069.60 Cr in Mar'25, while total assets increased from 945.02 Cr to 1,069.60 Cr in the same period. Cash flow from operating activities decreased from 141.00 Cr in Mar'23 to 65.00 Cr in Mar'25, but net cash inflow improved from 12.00 Cr to 39.00 Cr. Overall, the financial performance of Sr.Rayala.Hypo reflects a challenging environment with declining revenues and profits, yet some stabilization in cash flow and asset growth.

Is Sr.Rayala.Hypo overvalued or undervalued?

As of October 14, 2025, Sr.Rayala.Hypo is considered an attractive investment due to its undervaluation compared to peers in the commodity chemicals industry, with a PE ratio of 9.98, significantly lower than competitors like Solar Industries and Gujarat Fluoroch, despite a recent stock decline of 34.32% compared to the Sensex.

As of 14 October 2025, the valuation grade for Sr.Rayala.Hypo has moved from fair to attractive, indicating a more favorable assessment of the company's stock. The company is currently considered undervalued, especially when compared to its peers in the commodity chemicals industry. Key ratios include a PE ratio of 9.98, an EV to EBITDA of 6.47, and a PEG ratio of 0.51, which suggest that the stock is trading at a significant discount relative to its earnings growth potential.<BR><BR>In comparison to peers, Sr.Rayala.Hypo's PE ratio is substantially lower than Solar Industries, which has a PE of 99.77, and Gujarat Fluoroch at 64.04, both categorized as very expensive. Additionally, Godrej Industries, another attractive peer, has a PE of 35.44, further highlighting Sr.Rayala.Hypo's relative undervaluation. Despite recent stock performance lagging behind the Sensex, particularly over the past year with a decline of 34.32% compared to a slight increase in the Sensex, the current valuation metrics suggest that Sr.Rayala.Hypo presents a compelling investment opportunity.

Is Sr.Rayala.Hypo technically bullish or bearish?

As of October 1, 2025, the technical trend has shifted to a moderately strong bearish stance, supported by bearish MACD, moving averages, and Bollinger Bands, along with underperformance against the Sensex.

As of 1 October 2025, the technical trend has changed from mildly bearish to bearish. The current technical stance is bearish with a moderate strength. Key indicators driving this stance include a bearish MACD on the weekly timeframe, bearish moving averages on the daily timeframe, and bearish Bollinger Bands on the weekly timeframe. The KST and OBV also indicate a mildly bearish trend on the weekly basis. The stock has underperformed significantly compared to the Sensex across multiple time frames, further reinforcing the bearish outlook.

Who are the top shareholders of the Sr.Rayala.Hypo?

The top shareholders of Sr.Rayala.Hypo include Gowri Gopal Hospitals Private Limited with 21.8%, and individual investors who own 25.85%. There are minimal holdings from mutual funds and foreign institutional investors, with no pledged promoter holdings or significant public shareholders.

The top shareholders of Sr.Rayala.Hypo are primarily the promoters, with Gowri Gopal Hospitals Private Limited holding the largest stake at 21.8%. Additionally, individual investors collectively own 25.85% of the company. There are also some holdings by mutual funds and foreign institutional investors, but these represent a very small percentage of the overall ownership. Notably, there are no pledged promoter holdings or significant public shareholders.

Has Sr.Rayala.Hypo declared dividend?

Sree Rayalaseema Hi-Strength Hypo Ltd has declared a 30% dividend, amounting to 3 per share, with an ex-date of September 12, 2024. The dividend yield is 0.44%, and while the company has shown strong long-term returns, it experienced a -9.3% total return over the last 6 months.

Sree Rayalaseema Hi-Strength Hypo Ltd has declared a 30% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 30%<BR>- Amount per share: 3 per share<BR>- Ex-date: 12 Sep 24<BR><BR>Dividend Yield: 0.44%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -9.3%, the dividend return was 0%, resulting in a total return of -9.3%.<BR><BR>Over the past year, the price return was 26.45%, the dividend return was 0.54%, leading to a total return of 26.99%.<BR><BR>In the 2-year period, the price return was 4.28%, the dividend return was 1.11%, culminating in a total return of 5.39%.<BR><BR>For the 3-year period, the price return was 41.76%, the dividend return was 2.63%, which resulted in a total return of 44.39%.<BR><BR>In the last 4 years, the price return was 116.37%, the dividend return was 3.89%, yielding a total return of 120.26%.<BR><BR>Over the past 5 years, the price return was 516.93%, the dividend return was 12.61%, resulting in a total return of 529.54%.<BR><BR>Overall, while the company has declared a dividend, the recent total returns show mixed performance, with significant gains over longer periods but a negative return in the last 6 months. The dividend yield remains relatively low at 0.44%.